Skip to main content
. 2019 Apr 5;11(4):484. doi: 10.3390/cancers11040484

Figure 2.

Figure 2

Progression-free survival comparison between gemcitabine plus nab paclitaxel and FOLFIRINOX. CI: confidence interval, GEM + NAB-P: gemcitabine plus nab paclitaxel, IV: interval variable, SE: standard error.